Artivion, Inc. (AORT) Stock Price

AORTStock

$26.38−40.02%52W

Market Cap$1.29B

P/E140.78x

PEG Ratio—

Div yield—

Beta1.23

AORT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.58%

Price vs S&P 500 (4W)-3.50%

VGM Score45.90

P/E Ratio (Annual)140.78x

P/CF (Annual)34.48x

Book Value / Share (Quarterly)$9.29

P/TBV (Annual)7.41x

Revenue Growth (3Y)12.04%

Cash Flow / Share (Quarterly)$0.30

Price vs S&P 500 (YTD)-53.00%

Gross Margin (TTM)64.55%

Net Profit Margin (TTM)2.55%

EPS (TTM)$0.24

10-Day Avg Trading Volume0.76M

EPS Excl Extra (TTM)$0.24

Revenue Growth (5Y)11.75%

EPS (Annual)$0.21

ROI (Annual)1.46%

Gross Margin (Annual)64.40%

Net Profit Margin (5Y Avg)-4.20%

Cash / Share (Quarterly)$1.15

P/E Basic Excl Extra (TTM)117.64x

Revenue Growth QoQ (YoY)17.54%

P/E Normalized (Annual)140.78x

ROA (Last FY)1.10%

Revenue Growth TTM (YoY)17.59%

EBITD / Share (TTM)$0.86

ROE (5Y Avg)-5.05%

Operating Margin (TTM)6.04%

Cash Flow / Share (Annual)$0.02

P/B Ratio3.05x

P/B Ratio (Quarterly)3.94x

Net Income / Employee (Annual)$5,400

EV / Revenue (TTM)3.35x

Net Interest Coverage (TTM)1.79x

ROA (TTM)1.35%

EV / EBITDA (TTM)36.62x

EPS Incl Extra (Annual)$0.21

Current Ratio (Annual)3.53x

Quick Ratio (Quarterly)2.32x

3-Month Avg Trading Volume0.74M

52-Week Price Return-40.02%

EV / Free Cash Flow (Annual)1833.93x

P/E Incl Extra (TTM)117.64x

Revenue / Employee (TTM)$254,800

Tangible BV / Share (Quarterly)$6.09

P/S Ratio (Annual)3.12x

Asset Turnover (Annual)0.50x

52-Week High$48.25

Operating Margin (5Y Avg)2.27%

EPS Excl Extra (Annual)$0.21

CapEx CAGR (5Y)39.74%

26-Week Price Return-28.33%

Quick Ratio (Annual)2.20x

13-Week Price Return18.09%

Total Debt / Equity (Annual)0.49x

Current Ratio (Quarterly)3.86x

Enterprise Value$1.54B

Revenue / Share Growth (5Y)6.95%

Asset Turnover (TTM)0.53x

Book Value / Share Growth (5Y)-1.62%

Revenue / Employee (Annual)$245,200

Inventory Turnover (Annual)1.82x

Pretax Margin (Annual)3.35%

Cash / Share (Annual)$1.36

3-Month Return Std Dev46.77%

Gross Margin (5Y Avg)64.76%

Net Income / Employee (TTM)$6,500

EBITDA CAGR (5Y)18.96%

EBITDA Interim CAGR (5Y)10.60%

ROE (Last FY)2.18%

Net Interest Coverage (Annual)1.93x

EPS Basic Excl Extra (Annual)$0.21

P/FCF (TTM)36.10x

Receivables Turnover (TTM)5.11x

EV / Free Cash Flow (TTM)105.53x

Total Debt / Equity (Quarterly)0.49x

EPS Incl Extra (TTM)$0.24

Receivables Turnover (Annual)5.22x

ROI (TTM)1.78%

P/S Ratio (TTM)3.00x

Pretax Margin (5Y Avg)-2.88%

Revenue / Share (Annual)$9.36

Tangible BV / Share (Annual)$6.10

Forward P/E317.25x

Free OCF CAGR (5Y)-30.14%

Price vs S&P 500 (52W)-58.33%

P/E Ratio (TTM)117.64x

Year-to-Date Return-41.04%

5-Day Price Return-6.96%

EPS Normalized (Annual)$0.21

ROA (5Y Avg)-1.77%

Net Profit Margin (Annual)2.21%

Month-to-Date Return0.22%

Cash Flow / Share (TTM)$-0.05

EBITD / Share (Annual)$0.82

Operating Margin (Annual)5.46%

LT Debt / Equity (Annual)0.48x

P/CF (TTM)23.72x

ROI (5Y Avg)-2.32%

P/E Excl Extra (TTM)117.64x

LT Debt / Equity (Quarterly)0.48x

EPS Basic Excl Extra (TTM)$0.24

P/TBV (Quarterly)6.01x

P/B Ratio (Annual)4.82x

Inventory Turnover (TTM)1.81x

Pretax Margin (TTM)3.80%

Book Value / Share (Annual)$9.37

Price vs S&P 500 (13W)15.30%

Beta1.23x

P/FCF (Annual)1639.06x

Revenue / Share (TTM)$9.22

ROE (TTM)2.66%

52-Week Low$19.16

vGradeC

gGradeC

mGradeC

vgmGradeC

AORT Earnings Surprise History

Q2 250.24est. 0.13

Q3 250.16est. 0.15

Q4 250.17est. 0.18

Q1 260.08est. 0.12

Q2 260.13est. 0.10

AORT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.31

4.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
AORTArtivion, Inc.	C	C	C	$26.38
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About Artivion, Inc.

Artivion provides cardiac and vascular surgeons with aortic-centric surgical solutions, including heart valves, stent grafts, patches, and surgical sealants. The company operates through two segments: Medical Devices (implantable products and surgical tools) and Preservation Services (tissue preservation). With global operations across North America, EMEA, LATAM, and APAC, North America represents its largest revenue source.